It’s safe to donate blood during COVID-19, and critical for patients
March 16, 2020 07:00 ET
|
Canadian Blood Services
OTTAWA, March 16, 2020 (GLOBE NEWSWIRE) -- Canadian Blood Services is concerned by a recent spike in appointment cancellations in several cities related to the COVID-19 pandemic. As the...
COVID-19 : continuez à donner du sang, c’est vital pour les patients!
March 16, 2020 07:00 ET
|
Société canadienne du sang
OTTAWA, 16 mars 2020 (GLOBE NEWSWIRE) -- En raison de la pandémie de COVID-19, la Société canadienne du sang connaît actuellement un volume élevé d’annulations de rendez-vous dans plusieurs villes. ...
VitalHub Announces Patient Flow Solution to Address Needs of COVID-19 Pandemic
March 13, 2020 07:30 ET
|
Vitalhub Corp.
TORONTO, March 13, 2020 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) announced today the development of a patient flow and data visibility solution to assist in...
SERINUS CARE-AT-HOME LEADING SOLUTION TO FIGHT CORONA VIRUS COVID 19 PANDEMIC
March 12, 2020 22:30 ET
|
Serinus Health Inc
FT. LAUDERDALE, Fla., March 12, 2020 (GLOBE NEWSWIRE) -- Medicare and CDC have strongly recommended: “Stay home: People who are mildly ill with COVID-19 are able to isolate at home during their...
Patchwork measures not adequate say health providers, in response to Ford and Trudeau governments’ announcements on COVID-19
March 12, 2020 09:35 ET
|
Decent Work & Health Network
TORONTO, March 12, 2020 (GLOBE NEWSWIRE) -- A coalition of health professionals, represented by the Decent Work and Health Network, held a press conference today at Queen’s Park to urge the Ontario...
Innovation Pharmaceuticals Announces Testing Procedures of Brilacidin Against Coronavirus (COVID-19)
March 12, 2020 08:00 ET
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., March 12, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today research procedures that one...
U.S. Regional Biocontainment Lab to Begin Testing of Brilacidin Against Coronavirus (COVID-19) Next Week
March 10, 2020 08:20 ET
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., March 10, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to inform shareholders that...
Innovation Pharmaceuticals Brilacidin Received by U.S. Regional Biocontainment Laboratory; Testing Against Coronavirus (COVID-19)
March 09, 2020 08:00 ET
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., March 09, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announces today the Company has been...
Innovation Pharmaceuticals Signs Second MTA to Explore Brilacidin as Coronavirus COVID-19 Treatment
March 06, 2020 09:15 ET
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., March 06, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, continues to receive inquiries regarding the...
Dynavax Announces Collaboration with the University of Queensland and the Coalition for Epidemic Preparedness (CEPI) Focused on the Development of a Coronavirus (COVID-19) Vaccine
March 02, 2020 08:00 ET
|
Dynavax Technologies Corporation
EMERYVILLE, Calif., March 02, 2020 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today...